1.3 USD
-0.02 (-1.52%)
TELO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 190 industry peers in the Pharmaceuticals industry. TELO has a great financial health rating, but its profitability evaluates not so good. TELO is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
- TELO had negative earnings in the past year.
- In the past year TELO has reported a negative cash flow from operations.
1.2 Ratios
- Looking at the Return On Assets, with a value of -151.99%, TELO is doing worse than 85.79% of the companies in the same industry.
- TELO's Return On Equity of -161.20% is on the low side compared to the rest of the industry. TELO is outperformed by 71.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -151.99% | ||
| ROE | -161.2% | ||
| ROIC | N/A |
ROA(3y)-1092.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for TELO so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- TELO has more shares outstanding than it did 1 year ago.
- TELO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- TELO has an Altman-Z score of 53.12. This indicates that TELO is financially healthy and has little risk of bankruptcy at the moment.
- The Altman-Z score of TELO (53.12) is better than 95.26% of its industry peers.
- There is no outstanding debt for TELO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 53.12 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- TELO has a Current Ratio of 17.51. This indicates that TELO is financially healthy and has no problem in meeting its short term obligations.
- The Current ratio of TELO (17.51) is better than 86.84% of its industry peers.
- A Quick Ratio of 17.51 indicates that TELO has no problem at all paying its short term obligations.
- TELO's Quick ratio of 17.51 is amongst the best of the industry. TELO outperforms 86.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 17.51 | ||
| Quick Ratio | 17.51 |
3. Growth
3.1 Past
- TELO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.04%, which is quite impressive.
EPS 1Y (TTM)64.04%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%83.19%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, TELO will show a very strong growth in Earnings Per Share. The EPS will grow by 21.72% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y29.63%
EPS Next 2Y21.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
- TELO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year TELO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- TELO's earnings are expected to grow with 21.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.72%
EPS Next 3YN/A
5. Dividend
5.1 Amount
- No dividends for TELO!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TELOMIR PHARMACEUTICALS INC / TELO FAQ
Can you provide the ChartMill fundamental rating for TELOMIR PHARMACEUTICALS INC?
ChartMill assigns a fundamental rating of 3 / 10 to TELO.
What is the valuation status of TELOMIR PHARMACEUTICALS INC (TELO) stock?
ChartMill assigns a valuation rating of 1 / 10 to TELOMIR PHARMACEUTICALS INC (TELO). This can be considered as Overvalued.
What is the profitability of TELO stock?
TELOMIR PHARMACEUTICALS INC (TELO) has a profitability rating of 0 / 10.
Can you provide the expected EPS growth for TELO stock?
The Earnings per Share (EPS) of TELOMIR PHARMACEUTICALS INC (TELO) is expected to grow by 29.63% in the next year.